Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Scaletta

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|December 8, 2015
Primary chemotherapy versus primary surgery for ovarian cancerGiuseppe Scaletta, Francesco Plotti, Alessia Aloisi, et al.
Updates in Surgery|April 22, 2019
Management of postoperative chylous ascites after surgery for ovarian cancer: a single-institution experienceGiuseppe Scaletta, Lorena Quagliozzi, Stefano Cianci, et al.
Minerva Ginecologica|January 25, 2017
Undescended or absent ovary without uterine anomalies: systematic review and a single center's experienceDaniela Luvero, Francesco Plotti, Stella Capriglione, et al.
Minerva Ginecologica|December 11, 2020
Update on new imaging technologies in sentinel node detectionSilvia Pelligra, Giuseppe Scaletta, Stefano Cianci, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2020
Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysisEmanuele Rinninella, Anna Fagotti, Marco Cintoni, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 5, 2015
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up programRoberto Angioli, Stella Capriglione, Giuseppe Scaletta, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 12, 2015
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled studyStella Capriglione, Francesco Plotti, Andrea Miranda, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 30, 2018
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literatureStella Capriglione, Francesco Plotti, Corrado Terranova, et al.
Gynecologic Oncology|October 19, 2016
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trialStella Capriglione, Francesco Plotti, Roberto Montera, et al.
Minerva Medica|May 14, 2019
Sexual function and quality of life of patients affected by ovarian cancerStefano Cianci, Mattia Tarascio, Andrea Rosati, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|December 8, 2015
Primary chemotherapy versus primary surgery for ovarian cancerGiuseppe Scaletta, Francesco Plotti, Alessia Aloisi, et al.
Updates in Surgery|April 22, 2019
Management of postoperative chylous ascites after surgery for ovarian cancer: a single-institution experienceGiuseppe Scaletta, Lorena Quagliozzi, Stefano Cianci, et al.
Minerva Ginecologica|January 25, 2017
Undescended or absent ovary without uterine anomalies: systematic review and a single center's experienceDaniela Luvero, Francesco Plotti, Stella Capriglione, et al.
Minerva Ginecologica|December 11, 2020
Update on new imaging technologies in sentinel node detectionSilvia Pelligra, Giuseppe Scaletta, Stefano Cianci, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2020
Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysisEmanuele Rinninella, Anna Fagotti, Marco Cintoni, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 5, 2015
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up programRoberto Angioli, Stella Capriglione, Giuseppe Scaletta, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 12, 2015
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled studyStella Capriglione, Francesco Plotti, Andrea Miranda, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 30, 2018
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literatureStella Capriglione, Francesco Plotti, Corrado Terranova, et al.
Gynecologic Oncology|October 19, 2016
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trialStella Capriglione, Francesco Plotti, Roberto Montera, et al.
Minerva Medica|May 14, 2019
Sexual function and quality of life of patients affected by ovarian cancerStefano Cianci, Mattia Tarascio, Andrea Rosati, et al.
Pageof 5